BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27613281)

  • 1. Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.
    Liu Y; Shields LBE; Gao Z; Wang Y; Zhang YP; Chu T; Zhu Q; Shields CB; Cai J
    Mol Neurobiol; 2017 Sep; 54(7):5563-5572. PubMed ID: 27613281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor--key mediator in neuroinjury?
    Frerichs KU; Feuerstein GZ
    Cerebrovasc Brain Metab Rev; 1990; 2(2):148-60. PubMed ID: 2201347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation.
    Yamaguchi M; Matsui M; Higa R; Yamazaki Y; Ikari A; Miyake M; Miwa M; Ishii S; Sugatani J; Shimizu T
    Biochem Pharmacol; 2015 Feb; 93(4):482-95. PubMed ID: 25577975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of platelet activating factor (PAF) in physiology and pathology of the central nervous system].
    Farbiszewski R; Dudek H; Skrzydlewska E; Lewko J
    Neurol Neurochir Pol; 2002; 36(4):801-8. PubMed ID: 12418143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses.
    Yost CC; Weyrich AS; Zimmerman GA
    Biochimie; 2010 Jun; 92(6):692-7. PubMed ID: 20167241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases.
    Edwards LJ; Constantinescu CS
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):182-90. PubMed ID: 19601878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.
    Zimmerman GA; McIntyre TM; Prescott SM; Stafforini DM
    Crit Care Med; 2002 May; 30(5 Suppl):S294-301. PubMed ID: 12004251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor and pain.
    Tsuda M; Tozaki-Saitoh H; Inoue K
    Biol Pharm Bull; 2011; 34(8):1159-62. PubMed ID: 21804199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.
    Ryan SD; Harris CS; Mo F; Lee H; Hou ST; Bazan NG; Haddad PS; Arnason JT; Bennett SA
    J Neurochem; 2007 Oct; 103(1):88-97. PubMed ID: 17877634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor: A potential biomarker in acute coronary syndrome?
    Palur Ramakrishnan AV; Varghese TP; Vanapalli S; Nair NK; Mingate MD
    Cardiovasc Ther; 2017 Feb; 35(1):64-70. PubMed ID: 27790832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor.
    Brewer C; Bonin F; Bullock P; Nault MC; Morin J; Imbeault S; Shen TY; Franks DJ; Bennett SA
    J Neurochem; 2002 Sep; 82(6):1502-11. PubMed ID: 12354298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
    Hostettler ME; Knapp PE; Carlson SL
    Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway.
    Nagase T; Ishii S; Shindou H; Ouchi Y; Shimizu T
    Am J Respir Crit Care Med; 2002 Jan; 165(2):200-5. PubMed ID: 11790655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid toxicity and platelet-activating factor signaling.
    Sirangelo I; Irace G; Balestrieri ML
    J Cell Physiol; 2013 Jun; 228(6):1143-8. PubMed ID: 23169529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
    Lukashova V; Chen Z; Duhé RJ; Rola-Pleszczynski M; Stanková J
    J Immunol; 2003 Oct; 171(7):3794-800. PubMed ID: 14500680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.
    Gill P; Jindal NL; Jagdis A; Vadas P
    J Allergy Clin Immunol; 2015 Jun; 135(6):1424-32. PubMed ID: 26051949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor in the eye: Physiological roles, diseases and future perspectives.
    Dalmaso B; da Silva-Junior IA; Fragel-Madeira L; Jancar S; Del Debbio CB
    Prostaglandins Other Lipid Mediat; 2021 Apr; 153():106522. PubMed ID: 33358892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor in the CNS.
    Maclennan KM; Smith PF; Darlington CL
    Prog Neurobiol; 1996 Dec; 50(5-6):585-96. PubMed ID: 9015828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.
    Damiani E; Ullrich SE
    Prog Lipid Res; 2016 Jul; 63():14-27. PubMed ID: 27073146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor receptor.
    Honda Z; Ishii S; Shimizu T
    J Biochem; 2002 Jun; 131(6):773-9. PubMed ID: 12038971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.